[ARWR] QoQ Quarter Result on 30-Sep-2012 [#Q4]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
28-Dec-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q4]
Profit Trend
QoQ- 33.51%
YoY- -91.36%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 44 44 159 44 48 31 24 49.84%
PBT -6,178 -6,940 -4,781 -5,601 -8,240 -5,584 -2,687 74.29%
Tax -248,228 -70 -166,550 -22,110,563 -8,239,737 402 -2,686,579 -79.59%
NP -6,079 -6,758 -4,614 -5,314 -7,992 -5,335 -2,486 81.60%
Tax Rate - - - - - - - -
Total Cost 6,123 6,802 4,773 5,357 8,039 5,366 2,509 81.36%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin -13,894.88 -15,446.71 -2,901.69 -12,145.56 -16,677.82 -17,072.75 -10,374.43 21.52%
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
EPS -0.23 -0.41 -0.33 -0.38 -0.71 -0.50 -0.25 -5.41%
EPS Diluted -0.23 -0.41 -0.33 -0.38 -0.71 -0.50 -0.25 -5.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.